Literature DB >> 3195332

Spontaneous growth in Turner's syndrome.

M B Ranke1, P Stubbe, F Majewski, J R Bierich.   

Abstract

Growth in Turner's syndrome can be divided into four phases: intrauterine growth is slightly retarded, normal growth occurs up to a bone age of about 3 years, with a tendency to compensate for the loss in growth during intrauterine life, stunting of growth is severe during childhood, after a bone age of about 10 years - the time when puberty normally starts - the growth phase is prolonged, but total height gain is not essentially reduced. Based on a study of 150 patients with Turner's syndrome whose spontaneous growth was observed, standards of height and height velocity (means and SDs) were calculated to allow mathematical analysis of the spontaneous growth and growth during treatment in these patients. The auxological characteristics in Turner's syndrome do not support the assumption that GH deficiency plays a primary role in the pathogenesis of the growth disorder.

Entities:  

Mesh:

Year:  1988        PMID: 3195332     DOI: 10.1111/j.1651-2227.1988.tb10796.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  15 in total

Review 1.  Turner syndrome and GH treatment: the state of the art.

Authors:  A M Pasquino
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

2.  Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.

Authors:  A M Pasquino; I Pucarelli; M Segni; L Tarani; V Calcaterra; D Larizza
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

3.  Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1-22 years.

Authors:  M Sempé; C Hansson Bondallaz; C Limoni
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

4.  Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).

Authors:  Y Rakover; S Dietsch; G R Ambler; C Chock; M Thomsett; C T Cowell
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

5.  Growth hormone therapy for Turner syndrome--is it indicated?

Authors:  G Singh; M Suri
Journal:  Indian J Pediatr       Date:  1993 Jan-Feb       Impact factor: 1.967

6.  Molecular diagnosis of Turner's syndrome.

Authors:  C Gicquel; S Cabrol; H Schneid; F Girard; Y Le Bouc
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

7.  Growth charts for Down's syndrome from birth to 18 years of age.

Authors:  A Myrelid; J Gustafsson; B Ollars; G Annerén
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

8.  Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.

Authors:  C Rongen-Westerlaken; J M Wit; S M De Muinck Keizer-Schrama; B J Otten; W Oostdijk; H A Delemarre-van der Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

9.  Influence of HLA genotype on birth weight of patients with Turner syndrome.

Authors:  D Larizza; M Martinetti; C Pizzochero; M Cuccia; F Severi
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

10.  Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review.

Authors:  Christina Southern Reh; Mitchell E Geffner
Journal:  Clin Pharmacol       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.